Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Small business owners can enhance their wealth with smart strategies. Learn how to grow your assets effectively.
21,863 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
USA Compression Partners reports record cash flow for 2025 and a path to a 1.6x-plus distribution coverage in 2026, e...
Is Occidental Petroleum a solid buy, a risky hold, or a limited-scope sell? This guide breaks down the business, the ...
This article breaks down what to expect from the NESR 2026 earnings call, including key revenue drivers, profitabilit...
A veteran market watcher warns that AI-powered competition is eroding monopoly profits, signaling a brutal reset for ...
In 2026, investors face a pivotal choice between the world's largest gold producer and a nimble challenger. This arti...
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
American Water Works raised its quarterly dividend by 8% to $0.895 per share, a move funded by regulator-approved rat...
The Knicks’ ticker-tape parade conquering headlines signals a broader shift toward digital celebrations and paperless...
A forecast from Google Gemini AI points to a dramatic Sandisk rally by late 2026, driven by AI infrastructure需求 and t...